Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Madison Sports & Entertainment Group Inc C.MSET


Primary Symbol: MSET

Consumer Cyclical Leisure


GREY:MSET - Post by User

Madison Sports & Entertainment Group Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(14)
•••
Post by KanyesRabbion Mar 25, 2022 6:17am
300 Views
Post# 34544257

Mindset Pharma is about to be ….

Mindset Pharma is about to be ….

Mindset Pharma is about to be discovered by the masses as it is now being mentioned in association with the top 5 companies in the sector. 


  https://www.benzinga.com/markets/cannabis/22/03/26284541/five-companies-developing-second-generation-psychedelics-for-mental-health#.Yjy3vQmLLBc.twitter


 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities